Skip to main content
. 2015 Nov 25;10(11):e0142641. doi: 10.1371/journal.pone.0142641

Table 2. Baseline characteristics transplanted participants.

Transplanted organ Disease before transplantation Time since Tx (years)*1 Gender (M/F) Age (years) BMI (kg/m2) Peak load (W) VO2max (ml/min/kg) CPET criterion*2 Quadriceps strength (% pred.) Grip strength (%pred.)
1 Lung IPF 19 M 56 22.5 210 36.8 Good 84 88
2 Lung PAH 7 F 44 24.1 220 32.7 Good 111 113
3 Heart Cong. AV-block 3 F 22 21.8 198 35.0 Good 65 133
4 Heart HCM 4 F 57 22.7 175 28.0 Good 94 104
5 Kidney, test 1 IgA nephropathy 1 M 35 25.0 215 27.6 - 85 116
test 2 ± 25.0 240 42.5 Good - -
6 Kidney IgA nephropathy 2 F 28 29.8 212 30.1 Fair 58 109
7 Liver Tyrosinemia type 1 22 M 23 24.0 280 45.2 Good 79 129
8 Liver PSC 6 F 52 22.1 148 36.9 Excellent 75 108
9 Liver PSC 2 M 44 25.3 308 36.6 Fair 102 83
10 Liver, test 1 PSC 3 M 43 24.1 248 27.7 - 77 94
test 2 + 22.9 300 39.0 Good - -
11 Stem cell CML 8 M 31 24.4 305 44.4 Good 71 98
12 Small-bowel Bowel resection after thrombosis 2 F 54 24.3 134 26.8 Fair 81 91
Median 3.5 6M/ 6F 43.5 24.1 212 36.7 - 80 106
IQR 2.0–7.75 28.8–53.5 22.6–25.1 175–300 30.8–41.6 - 72–92 92–115

± Second test due to abortion of Test 1 due to high blood pressure; the second test was an Astrand cycle ergometer test.

+ Second test due to insufficient performance for Test 1; Test 2 performed ten weeks after Test 1. IQR: inter quartile range. IPF: idiopathic pulmonary fibrosis, PAH: pulmonary arterial hypertension, HCM: hypertrophic cardiomyopathy, PSC: primary sclerosing cholangitis, CML: chronic myeloid leukemia. Tx: transplantation.

*1Time since Tx in years on date of departure to Tanzania.

*2 CPET criterion: cardio pulmonary exercise testing, criterion according to the American College of Sports Medicine [11].